Headline

The latest stories from AHA Today.

As pediatric and adult hospitalization rates for flu and COVID-19 increase, AHA’s United Against the Flu campaign released a new social media toolkit to help hospitals and health systems encourage their communities to get vaccinated, including getting the updated COVID-19 booster. 
U.S. spending on health care grew just 2.7% in 2021 as federal expenditures for health care declined after spiking in 2020 due to the COVID-19 pandemic, the Centers for Medicare & Medicaid Services reported today in Health Affairs.
The Biden Administration has named 17 members to the Ground Ambulance and Patient Billing Advisory Committee, the Centers for Medicare & Medicaid Services announced.
A bipartisan group of 113 House members yesterday urged President Biden and congressional leaders to prevent additional impending Medicare cuts from going into effect, including the Statutory Pay-As-You-Go sequester. 
The House later today is expected to pass a continuing resolution extending the current federal funding levels for health care and other programs through Dec. 23.
The Centers for Medicare & Medicaid Services yesterday released its proposed standards for qualified health plans offered through the health insurance marketplaces for 2024.
The Substance Abuse and Mental Health Services Administration proposed updating opioid treatment program standards and admission criteria to expand access to treatment.
The Food and Drug Administration last week authorized for emergency use a test kit to help identify individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection. Only laboratories certified under the Clinical Laboratory Improvement Amendments that meet…
States and health care providers may use regulatory flexibilities available during the COVID-19 public health emergency to help respond to non-COVID-19 illnesses straining hospital and health care systems, such as flu and Respiratory Syncytial Virus, Health and Human Services Secretary Xavier…
The Centers for Disease Control and Prevention today recommended the Moderna and Pfizer bivalent COVID-19 vaccines in children as young as 6 months old.